BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19834662)

  • 41. Educational deficits in survivors of childhood cancer.
    Peckham VC
    Pediatrician; 1991; 18(1):25-31. PubMed ID: 1983857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study.
    Decaudin D; Brousse N; Brice P; Haioun C; Bourhis JH; Morel P; Van Hoof A; Souleau B; Quesnel B; Gisselbrecht C
    Bone Marrow Transplant; 2000 Feb; 25(3):251-6. PubMed ID: 10673695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term endocrine sequelae of childhood cancer.
    Rutter MM; Rose SR
    Curr Opin Pediatr; 2007 Aug; 19(4):480-7. PubMed ID: 17630615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
    Costa LJ; Rodriguez V; Porrata LF; Lacy MQ; Elliott MA; Gertz MA; Gastineau DA; Litzow MR
    Bone Marrow Transplant; 2008 Oct; 42(7):497-8. PubMed ID: 18622421
    [No Abstract]   [Full Text] [Related]  

  • 46. Late effects following hematopoietic cell transplantation for children.
    Dahllöf G; Hingorani SR; Sanders JE
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):88-93. PubMed ID: 18162227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High dose therapy and autologous hematopoietic stem cell transplantation in poor risk solid tumors of childhood.
    Dallorso S; Manzitti C; Morreale G; Faraci M
    Haematologica; 2000 Nov; 85(11 Suppl):66-70. PubMed ID: 11268328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of autologous transplantation in the treatment of malignant disorders.
    Territo M
    J Rheumatol Suppl; 1997 May; 48():36-40. PubMed ID: 9150116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successive double high-dose chemotherapy with peripheral blood stem cell rescue collected during a single leukapheresis round in patients with high-risk pediatric solid tumors: a pilot study in a single center.
    Sung KW; Yoo KH; Chung EH; Jung HL; Koo HH; Shin HJ; Lee SK; Lim DH; Kim DW; Park HK; Cho EJ; Kim SW
    Bone Marrow Transplant; 2003 Mar; 31(6):447-52. PubMed ID: 12665839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Late effects of antileukemic treatment.
    Ochs J; Mulhern RK
    Pediatr Clin North Am; 1988 Aug; 35(4):815-33. PubMed ID: 3047655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endocrine sequelae in childhood cancer survivors.
    Casano Sancho P
    Endocrinol Diabetes Nutr; 2017 Nov; 64(9):498-505. PubMed ID: 29050706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late-effects among survivors of leukaemia and lymphoma during childhood and adolescence.
    Robison LL; Bhatia S
    Br J Haematol; 2003 Aug; 122(3):345-59. PubMed ID: 12877662
    [No Abstract]   [Full Text] [Related]  

  • 53. [Late effects of treatment of childhood cancer - on the basis of the literature and own experience].
    Krawczuk-Rybak M
    Med Wieku Rozwoj; 2013; 17(2):130-6. PubMed ID: 23988370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropsychological late effects and rehabilitation following pediatric brain tumor.
    Gragert MN; Ris MD
    J Pediatr Rehabil Med; 2011; 4(1):47-58. PubMed ID: 21757810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on dyslipidemia and thyroid disorders].
    Cornillon J; Vantyghem MC; Couturier MA; de Berranger E; François S; Hermet E; Maillard N; Marcais A; Tabrizi R; Decanter C; Duléry R; Bauters F; Yakoub-Agha I;
    Pathol Biol (Paris); 2013 Aug; 61(4):168-70. PubMed ID: 24011967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Approaches to reduce the long-term burden of treatment-related complications in survivors of childhood cancer.
    Armenian SH; Kremer LC; Sklar C
    Am Soc Clin Oncol Educ Book; 2015; ():196-204. PubMed ID: 25993157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term survivors of childhood cancer: evaluation and identification of sequelae of treatment.
    DeLaat CA; Lampkin BC
    CA Cancer J Clin; 1992; 42(5):263-82. PubMed ID: 1515966
    [No Abstract]   [Full Text] [Related]  

  • 58. Second malignant neoplasms following hematopoietic stem cell transplantation.
    Friedman DL; Leisenring W; Schwartz JL; Deeg HJ
    Int J Hematol; 2004 Apr; 79(3):229-34. PubMed ID: 15168589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurocognitive sequelae of cancer treatment.
    Packer RJ; Mehta M
    Neurology; 2002 Jul; 59(1):8-10. PubMed ID: 12105300
    [No Abstract]   [Full Text] [Related]  

  • 60. Survivors of childhood cancer and risk of a second tumor.
    Robison LL
    J Natl Cancer Inst; 1993 Jul; 85(14):1102-3. PubMed ID: 8320735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.